Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.
about
A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapyExpression profiles of circulating cytokines, chemokines and immune cells in patients with hepatitis B virus infectionLoss of c-Met accelerates development of liver fibrosis in response to CCl(4) exposure through deregulation of multiple molecular pathways.Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis.Detection of host immune responses in acute phase sera of spontaneous resolution versus persistent hepatitis C virus infection.Inflammatory molecules expression pattern for identifying pathogen species in febrile patient serumCombined Detection of Serum IL-10, IL-17, and CXCL10 Predicts Acute Rejection Following Adult Liver Transplantation.Predictive Value of Serum IFN-γ inducible Protein-10 and IFN-γ/IL-4 Ratio for Liver Fibrosis Progression in CHB Patients.Therapeutic potential of chemokine receptor antagonists for liver disease.The interferon signaling pathway genes as biomarkers of hepatitis C virus disease progression and response to treatment.The role of chemokines in acute and chronic hepatitis C infection.Hepatitis C recurrence: the Achilles heel of liver transplantation.Transplantation and inflammation: implications for the modification of chemokine function.Recurrent HCV after liver transplantation-mechanisms, assessment and therapy.CXC chemokine IP-10: a key actor in liver disease?Early non-invasive selection of patients at high risk of severe hepatitis C recurrence after liver transplantation.Atypical Chemokine Receptor 1 Polymorphism can not Affect Susceptibility to Hepatitis C Virus.CXCL10 levels identify individuals with rapid fibrosis at 12 months post-transplant for hepatitis C virus and predict treatment response.TNFR1 determines progression of chronic liver injury in the IKKγ/Nemo genetic model.Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trial.Monitoring hepatitis C infection in the liver allograft.A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection.Proapoptotic effects of the chemokine, CXCL 10 are mediated by the noncognate receptor TLR4 in hepatocytes.Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality.
P2860
Q28480936-64F8345D-305E-446F-9645-0DB78CD4B8FDQ33808113-6EF2948C-E826-4500-AC3A-858338EA915DQ35918640-68C910E3-E73E-4B46-9264-EF8BD0E7B8EEQ36221675-2A281998-5A98-46AA-A4A3-4747B1A77225Q36523107-45064911-5C55-47F7-9992-0A65E062FE89Q37002132-1A209BC9-C298-4B22-8D71-8BE492CE69F9Q37188559-9F747F9E-BED0-4B76-B758-BDCB4CF69D7BQ37571093-8A69207F-DBE1-468F-9797-F0A884F3DCACQ37960533-E66699ED-C684-4D0B-8E24-26B0A634CB0CQ37997042-CC3B3472-F392-4556-87EA-BAF9E5C3661EQ38129709-9B4AA6AA-E86C-4701-8CDE-8C80845E3378Q38174194-8CB209FE-1126-4943-ACB2-46F6CA969B82Q38218886-25ADF3D5-02EF-4417-B81A-B3D3800C0688Q38229320-38B833CA-583E-4BAE-9A03-3C6465AC7E6AQ38552265-1275E422-6960-47A2-ACDA-3CCDE97AFB93Q39908420-57A2C9BB-2490-4755-90DE-10ADF2852BC2Q40227745-D356C24C-BB4E-4733-A883-B953D3A7B9E5Q42223349-EB930D89-D4CC-4F42-B719-7A513422A0D4Q42259539-4B233043-CDED-4121-859F-B20A4C3582E1Q42263066-E317A5EB-7E8C-4656-8340-65B984942325Q43063071-81FF7283-B0AF-4F25-97E3-CBEF4978B7CAQ45361290-1E8E6D33-8F4E-4B1A-8E28-DECBC5D5AB77Q45740965-6AC341EE-3903-4D39-8111-BA9A44E40AB4Q47438436-6E7FDBA3-96EC-4BBC-93E1-65D644AA2046
P2860
Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Serum chemokine CXC ligand 10 ...... ion for hepatitis C infection.
@en
Serum chemokine CXC ligand 10
@nl
type
label
Serum chemokine CXC ligand 10 ...... ion for hepatitis C infection.
@en
Serum chemokine CXC ligand 10
@nl
prefLabel
Serum chemokine CXC ligand 10 ...... ion for hepatitis C infection.
@en
Serum chemokine CXC ligand 10
@nl
P2093
P2860
P356
P1433
P1476
Serum chemokine CXC ligand 10 ...... ion for hepatitis C infection.
@en
P2093
Christian Trautwein
Dennis Eurich
Frank Tacke
Hermann E Wasmuth
Marcus Bahra
Marie-Luise Berres
Maximilian Schmeding
Ulf P Neumann
P2860
P304
P356
10.1002/HEP.24098
P407
P577
2011-01-10T00:00:00Z